Paper36061376
Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance.
Sundararaman SA and 1 other. Front Pediatr, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance. Papers, record 36061376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36061376
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11425176 | The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. | Am J Trop Med Hyg | 2001 | https://conductscience.org/library/papers/11425176 | PubMed |
| 2 | 9840604 | Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. | Am J Trop Med Hyg | 1998 | https://conductscience.org/library/papers/9840604 | PubMed |
| 3 | 21765069 | Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21765069 | PubMed |
| 4 | 33891721 | Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33891721 | PubMed |
| 5 | 28785011 | Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. | Sci Rep | 2017 | https://conductscience.org/library/papers/28785011 | PubMed |
| 6 | 30922818 | Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/30922818 | PubMed |
| 7 | 14096460 | CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE. | Br Med J | 1964 | https://conductscience.org/library/papers/14096460 | PubMed |
| 8 | 24028889 | Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. | Trends Parasitol | 2013 | https://conductscience.org/library/papers/24028889 | PubMed |
| 9 | 11807721 | Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. | J Infect Dis | 2002 | https://conductscience.org/library/papers/11807721 | PubMed |
| 10 | 31345710 | Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/31345710 | PubMed |
| 11 | 400205 | Falciparum malaria and pregnancy. | Trans R Soc Trop Med Hyg | 1979 | https://conductscience.org/library/papers/400205 | PubMed |
| 12 | 22850522 | Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22850522 | PubMed |
| 13 | 30910321 | Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. | Lancet | 2019 | https://conductscience.org/library/papers/30910321 | PubMed |
| 14 | 33020152 | Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/33020152 | PubMed |
| 15 | 26325263 | Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis. | Trop Med Int Health | 2015 | https://conductscience.org/library/papers/26325263 | PubMed |
| 16 | 26962728 | Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26962728 | PubMed |
| 17 | 28968782 | Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28968782 | PubMed |
| 18 | 27622558 | Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. | PLoS Med | 2016 | https://conductscience.org/library/papers/27622558 | PubMed |
| 19 | 15482398 | Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. | Trop Med Int Health | 2004 | https://conductscience.org/library/papers/15482398 | PubMed |
| 20 | 32772921 | Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. | BMC Med | 2020 | https://conductscience.org/library/papers/32772921 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958321 | Placental malaria and preeclampsia: shared pathways and translational perspectives in endemic regions. | Malar J | 2026 | https://conductscience.org/library/papers/42958321 | PubMed |
| 42383988 | Indole-based hybrids target both asexual parasites and gametocytes of Plasmodium falciparum and synergize with lumefantrine. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42383988 | PubMed |
| 42198630 | Prevalence of pfdhfr-pfdhps Sextuple and Gametocyte-Associated Quintuple Sulfadoxine-Pyrimethamine Resistance Mutations in Plasmodium falciparum Isolates from Pregnant Women in Mozambique. | Pathogens | 2026 | https://conductscience.org/library/papers/42198630 | PubMed |
| 42188751 | Modelling the Cost-Effectiveness of a Placental Malaria Vaccine in Sub-Saharan Africa. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188751 | PubMed |
| 41824506 | Improving malaria chemoprevention coverage in pregnancy: Surveying stakeholder preferences for new product profiles and community-delivery approaches across five African countries. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/41824506 | PubMed |
| 41639729 | Malaria: a review on its current epidemiological status and management strategies. | Malar J | 2026 | https://conductscience.org/library/papers/41639729 | PubMed |
| 41469677 | Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda. | Malar J | 2025 | https://conductscience.org/library/papers/41469677 | PubMed |
| 41219797 | Polymorphism of the dihydropteroate synthase resistance gene of Plasmodium falciparum in three hospitals in Mbouda, Western Cameroon. | Trop Dis Travel Med Vaccines | 2025 | https://conductscience.org/library/papers/41219797 | PubMed |
| 41191181 | Advancing malaria treatment with magnetic and mesoporous silica nanoparticles loaded with sulfadoxine-pyrimethamine: a review. | Discov Nano | 2025 | https://conductscience.org/library/papers/41191181 | PubMed |
| 41001541 | Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda. | Res Sq | 2025 | https://conductscience.org/library/papers/41001541 | PubMed |
| 39806485 | Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study. | Malar J | 2025 | https://conductscience.org/library/papers/39806485 | PubMed |
| 37754682 | Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso. | Infect Immun | 2023 | https://conductscience.org/library/papers/37754682 | PubMed |
| 37090061 | Perceptions of sulphadoxine-pyrimethamine use among pregnant women in sub-Saharan Africa: a scoping review. | Malariaworld J | 2023 | https://conductscience.org/library/papers/37090061 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 | NCBI Gene |
| DHPS | 1725 | PubTator's text mining | https://conductscience.org/library/genes/1725 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36061376
GET https://conductscience.org/api/papers/v1/36061376/references?page=2